Cancer can spread into the fluid-filled layers around the brain and spinal cord
In short: Leptomeningeal cancer occurs when cancer cells reach the thin membranes wrapping the brain and spinal cord. It is most often seen with breast or lung cancer and melanoma. Because cerebrospinal fluid carries the disease through the nervous system, symptoms can vary widely, and treatment is hard. Learn why researchers find it so difficult to beat.
Leptomeningeal metastases mean cancer cells have spread into the leptomeninges, the thin tissue layers that cover the brain and spinal cord. The name comes from the Greek word lepto, meaning fine or slight, and describes the arachnoid and pia mater, between which cerebrospinal fluid flows. The condition can also be called neoplastic meningitis, leptomeningeal disease or carcinomatosis. It is a sign that cancer has reached an advanced stage.
Cancer cells can arrive by travelling in the bloodstream from a tumour elsewhere in the body, or by spreading from a secondary cancer already growing in the brain. Breast cancer, lung cancer and melanoma are the most common sources. Estimates suggest roughly 5 to 10 in every 100 people with cancer that has spread may develop it, while in blood cancers the estimate is 5 to 15 in every 100. Patients whose cancer has reached the posterior fossa at the base of the brain may face a higher risk.
Symptoms depend on where the cells settle, so almost any neurological problem is possible. Pain and seizures are the most common, and headaches, double vision, weakness, memory problems and bladder or bowel trouble also occur. Diagnosis can be difficult. It may show on an MRI scan, or cancer cells may be found in spinal fluid collected by lumbar puncture. Some chemotherapy drugs struggle to cross the blood-brain barrier, which protects the brain but also limits treatment.
Outlook is uncertain and depends on how far the cancer has spread, how fast it grows and how it responds to treatment. A systematic review of clinical trials reports a median overall survival of only about 2 to 6 months across studies, and says survival gains have stayed largely flat over the years. Newer targeted systemic therapies offer hope, and trials of intraventricular or intrathecal drug delivery are common, but researchers still describe the outlook as grim.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: What are leptomeningeal metastases?
- Also: Leptomeningeal cancer
- Also: The Evolving Landscape of Leptomeningeal Cancer from Solid Tumors: A Systematic Review of Clinical Trials.
To cite this card, link to https://intellectplus.co.uk/app/health-leptomeningeal-cancer.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Health, medicine and disease · More in Health · Latest · A–Z · All topics